India considers resuming Iranian oil imports after the US eases sanctions. Asian refiners explore options amid energy...
Month: March 2026
Indian firms launch generic semaglutide, challenging Novo Nordisk's Ozempic & Wegovy. Affordable access to diabetes & weight...
Dr. Reddy's Laboratories introduces Obeda, a semaglutide injectable, in India, enhancing their diabetes care portfolio. A new...
Dr. Reddy's Laboratories introduces 'Obeda', a semaglutide version for diabetes management in India. Aims to expand its...
Indian startups raised $228.4M across 21 deals amidst global market uncertainties. Fintech leads, followed by e-commerce. Key...
Dr. Reddy's introduces Obeda, a generic semaglutide injection, the first DCGI-approved treatment for Type 2 diabetes in...
Delhi Police seals United News of India (UNI) office following a Delhi High Court order related to...
Diesel prices surge in India due to geopolitical tensions, impacting manufacturing, logistics, and infrastructure. Industries face increased...
Can Alphabet's (GOOGL) stock reach $350 by year-end? Financial analysis examines growth, market factors, and the plausibility...
Indian airlines challenge a government order for free seat selection, warning of potential fare increases. The FIA...